GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SciSparc Ltd (NAS:SPRC) » Definitions » Total Equity

SPRC (SciSparc) Total Equity : $8.66 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is SciSparc Total Equity?

SciSparc's total equity for the quarter that ended in Jun. 2024 was $8.66 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

SciSparc Total Equity Historical Data

The historical data trend for SciSparc's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SciSparc Total Equity Chart

SciSparc Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 1.43 8.14 6.45 9.59

SciSparc Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.04 6.45 6.78 9.59 8.66

SciSparc Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

SciSparc's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=11.182-1.595
=9.59

SciSparc's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=10.482-1.826
=8.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SciSparc Total Equity Related Terms

Thank you for viewing the detailed overview of SciSparc's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

SciSparc Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SciSparc Ltd (NAS:SPRC) » Definitions » Total Equity
Comparable Companies
DRMA AMPE INM BXRX NBRVF SCPS ADTX CFRX RUBY GSTC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
20 Raul Wallenberg Street, Tower A, 2nd Floor, Tel Aviv, ISR, 6971916
Website
https://www.scisparc.com
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.